Author Question: A nurse is administering darbepoetin alfa to a client. The nurse checks the client's hemoglobin ... (Read 114 times)

luminitza · **on:** Jul 23, 2018

A nurse is administering darbepoetin alfa to a client. The nurse checks the client's hemoglobin level carefully during the administration based on the understanding that polycythemia can occur, leading to which of the following? Select all that apply.

A) Increased mortality
B) Tumor progression
C) Severe hypotension
D) Thromboembolic events
E) Cardiovascular events

Question 2

Based on the nurse's understanding of epoetin alfa, the nurse would expect to administer the drug cautiously to a client with a history of which of the following? Select all that apply.

A) Diabetes
B) Renal failure
C) History of seizures
D) Congestive heart failure
E) Hypotension

Question 3

A nurse notifies the primary health care provider because assessment reveals signs of thrombocytopenia, including which of the following? Select all that apply.

A) Bleeding gums
B) Petechiae
C) Tarry stools
D) Hematuria
E) Coffee-ground emesis

Question 4

A client with chronic kidney disease is prescribed epoetin alfa (Procrit). Which of the following would be appropriate for the nurse to do when administering this drug to promote optimal response? Select all that apply.

A) Shake the vial vigorously prior to administration.
B) Use the vial for multiple doses.
C) Discard any unused portion after administration.
D) Administer the drug either intravenously or subcutaneously.
E) Avoid using the drug if the client is receiving dialysis.

nmyers · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

Props to you, cheers.

Answer to Question 2

wohoo thank youuu.

Answer to Question 3

Props to you, cheers.

Answer to Question 4

Ans: C, D
Feedback:
When administering epoetin alfa (Procrit) to a client with chronic kidney disease, the following apply: the drug is given three times weekly IV or subcutaneously; if the client is receiving dialysis, the drug is administered into the venous access line; the drug is mixed gently during preparation for administration; shaking may denature the glycoprotein; and the vial is used for only one dose and any remaining or unused portion is discarded.